| The role of collagen in cancer: from bench to bedside S Xu, H Xu, W Wang, S Li, H Li, T Li, W Zhang, X Yu, L Liu Journal of translational medicine 17, 1-22, 2019 | 727 | 2019 |
| Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer SS Xu, S Li, HX Xu, H Li, CT Wu, WQ Wang, HL Gao, W Jiang, WH Zhang, ... World journal of gastroenterology 26 (8), 828, 2020 | 143 | 2020 |
| Follicular helper T cells remodel the immune microenvironment of pancreatic cancer via secreting CXCL13 and IL-21 X Lin, L Ye, X Wang, Z Liao, J Dong, Y Yang, R Zhang, H Li, P Li, L Ding, ... Cancers 13 (15), 3678, 2021 | 54 | 2021 |
| Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors WH Zhang, WQ Wang, X Han, HL Gao, SS Xu, S Li, TJ Li, HX Xu, H Li, ... Journal for ImmunoTherapy of Cancer 8 (2), 2020 | 52 | 2020 |
| Tumor-infiltrating neutrophils predict poor survival of non-functional pancreatic neuroendocrine tumor WH Zhang, WQ Wang, HL Gao, SS Xu, S Li, TJ Li, X Han, HX Xu, H Li, ... The Journal of Clinical Endocrinology & Metabolism 105 (7), 2217-2228, 2020 | 30 | 2020 |
| The tumor immune microenvironment in gastroenteropancreatic neuroendocrine neoplasms WH Zhang, WQ Wang, HL Gao, XJ Yu, L Liu Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1872 (2), 188311, 2019 | 30 | 2019 |
| Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor SS Xu, HX Xu, WQ Wang, S Li, H Li, TJ Li, WH Zhang, L Liu, XJ Yu World journal of gastroenterology 25 (41), 6248, 2019 | 29 | 2019 |
| Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective WH Zhang, WQ Wang, X Han, HL Gao, TJ Li, SS Xu, S Li, HX Xu, H Li, ... Computational and Structural Biotechnology Journal 18, 3606-3614, 2020 | 28 | 2020 |
| A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors WQ Wang, WH Zhang, HL Gao, D Huang, HX Xu, S Li, TJ Li, SS Xu, H Li, ... Journal of Gastroenterology 56, 395-405, 2021 | 27 | 2021 |
| Cancer-associated fibroblasts in therapeutic resistance of pancreatic cancer: Present situation, predicaments, and perspectives X Han, WH Zhang, WQ Wang, XJ Yu, L Liu Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1874 (2), 188444, 2020 | 23 | 2020 |
| Human splenic TER cells: A relevant prognostic factor acting via the artemin‐GFRα3‐ERK pathway in pancreatic ductal adenocarcinoma TJ Li, H Li, WH Zhang, SS Xu, W Jiang, S Li, HL Gao, X Han, HX Xu, ... International Journal of Cancer 148 (7), 1756-1767, 2021 | 21 | 2021 |
| Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer L Ye, K Jin, Z Liao, Z Xiao, H Xu, X Lin, H Li, T Li, W Zhang, X Han, ... EBioMedicine 79, 2022 | 18 | 2022 |
| MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression J Xu, Z Ye, Q Zhuo, H Gao, Y Qin, X Lou, W Zhang, F Wang, Y Wang, ... Cancer research 83 (13), 2226-2247, 2023 | 17 | 2023 |
| TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway H Li, W Jiang, XN Liu, LY Yuan, TJ Li, S Li, SS Xu, WH Zhang, HL Gao, ... Oncogene 39 (36), 5825-5838, 2020 | 17 | 2020 |
| Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma T Li, H Li, S Li, S Xu, W Zhang, H Gao, H Xu, C Wu, W Wang, X Yu, L Liu Cancer medicine 8 (11), 5223-5231, 2019 | 16 | 2019 |
| Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma SR Zhang, H Li, WQ Wang, W Jin, JZ Xu, HX Xu, CT Wu, HL Gao, S Li, ... European Journal of Surgical Oncology 45 (5), 769-775, 2019 | 11 | 2019 |
| Establishment and characterization of the third non-functional human pancreatic neuroendocrine tumor cell line X Lou, Z Ye, X Xu, M Jiang, R Lu, D Jing, W Zhang, H Gao, F Wang, ... Human cell 35 (4), 1248-1261, 2022 | 9 | 2022 |
| MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumors: MEN1 promotes ferroptosis in pancreatic neuroendocrine tumors Z Ye, H Chen, S Ji, Y Hu, X Lou, W Zhang, D Jing, G Fan, Y Zhang, ... Acta Biochimica et Biophysica Sinica 54 (11), 1599, 2022 | 7 | 2022 |
| Maximum value on arterial phase computed tomography predicts prognosis and treatment efficacy of sunitinib for pancreatic neuroendocrine tumours H Chen, Z Li, Y Hu, X Xu, Z Ye, X Lou, W Zhang, H Gao, Y Qin, Y Zhang, ... Annals of Surgical Oncology 30 (5), 2988-2998, 2023 | 6 | 2023 |
| Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer X Han, WH Zhang, HL Gao, TJ Li, HX Xu, H Li, PC Li, X Wang, XJ Yu, ... Journal of Clinical Laboratory Analysis 36 (7), e24517, 2022 | 5 | 2022 |
